No Data
No Data
Argus Research Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $125
Argus Research Reaffirms Their Buy Rating on Cardinal Health (CAH)
Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Jefferies Adjusts Price Target on Cardinal Health to $110 From $105
Children's Hospital Association and Cardinal Health Commemorate World Suicide Prevention Day With Continued Focus on Youth Mental Health
No Data
No Data